3,4-dihydroxyphenylglycol has been researched along with Parkinson Disease in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.76) | 18.7374 |
| 1990's | 3 (17.65) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 5 (29.41) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Goldstein, DS; Holmes, C; Lamotte, G; Lenka, A; Sharabi, Y; Sullivan, P | 1 |
| Goldstein, DS; Holmes, C; Kopin, IJ; Sharabi, Y | 1 |
| Goldstein, DS; Holmes, C; Kopin, IJ; Mash, DC; Sharabi, Y; Sullivan, P | 1 |
| Andersen, ML; Aurich, MF; da Cunha, C; Lima, MM; Noseda, AC; Rodrigues, LS; Targa, AD; Tufik, S | 1 |
| Bentho, O; Eldadah, BA; Goldstein, DS; Grossman, E; Holmes, C; Imrich, R; Pechnik, S; Sharabi, Y | 1 |
| Goldstein, DS; Holmes, C; Imrich, R; Pechnik, S; Sharabi, Y | 1 |
| Adar, L; Goren, T; Sasson, N; Weiss, YM | 1 |
| Gu, L; Sun, L; Wang, S; Yang, H; Yuan, J; Zhang, H; Zhu, J | 1 |
| Brentzel, S; Eisenhofer, G; Goldstein, DS; Holmes, C; Sharabi, Y | 1 |
| Albin, RL; Feeley Kearney, JA | 1 |
| Agari, T; Borlongan, CV; Date, I; Kondo, A; Kuramoto, S; Matsui, T; Miyoshi, Y; Shingo, T; Yasuhara, T | 1 |
| Edwards, DJ; Rizk, M; Spiker, DG | 1 |
| Ahlskog, JE; Low, PA; Nickander, KK; O'Brien, JF; Tyce, GM; Uitti, RJ | 1 |
| Ahlskog, JE; Kokmen, E; O'Brien, JF; Petersen, RC; Tyce, GM; Uitti, RJ | 1 |
| Bruce, S; Cannon, RO; Goldstein, DS; Holmes, C; Li, ST; Metman, LV | 1 |
| de Vries, JA; Fremouw-Ottevangers, DC; Muskiet, FA; Nagel, GT; Wolthers, BG | 1 |
| Blank, CL; Ikarashi, Y; Inoue, HK; Itoh, K; Maruyama, Y; Satoh, H | 1 |
1 trial(s) available for 3,4-dihydroxyphenylglycol and Parkinson Disease
| Article | Year |
|---|---|
Clinical pharmacology tyramine challenge study to determine the selectivity of the monoamine oxidase type B (MAO-B) inhibitor rasagiline.
Topics: Adult; Aged; Algorithms; Contraindications; Diet; Dose-Response Relationship, Drug; Double-Blind Method; Drug Labeling; Female; Humans; Hypertension; Indans; Isoenzymes; Male; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Selegiline; Tyramine; United States | 2010 |
16 other study(ies) available for 3,4-dihydroxyphenylglycol and Parkinson Disease
| Article | Year |
|---|---|
Differential abnormalities of cerebrospinal fluid dopaminergic versus noradrenergic indices in synucleinopathies.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Cohort Studies; Dopamine; Dopaminergic Neurons; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Multiple System Atrophy; Neurons; Norepinephrine; Parkinson Disease; Pure Autonomic Failure; Retrospective Studies; Synucleinopathies | 2021 |
Plasma biomarkers of decreased vesicular storage distinguish Parkinson disease with orthostatic hypotension from the parkinsonian form of multiple system atrophy.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Biomarkers; Case-Control Studies; Comorbidity; Cross-Sectional Studies; Diagnosis, Differential; Dopamine; Female; Fluorine Radioisotopes; Humans; Hypotension, Orthostatic; Male; Methoxyhydroxyphenylglycol; Middle Aged; Multiple System Atrophy; Parkinson Disease; Sensitivity and Specificity; Synaptic Vesicles | 2015 |
Decreased vesicular storage and aldehyde dehydrogenase activity in multiple system atrophy.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Aged, 80 and over; Aldehyde Dehydrogenase; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Frontal Lobe; Humans; Male; Methoxyhydroxyphenylglycol; Multiple System Atrophy; Neurons; Norepinephrine; Parkinson Disease | 2015 |
Unraveling a new circuitry for sleep regulation in Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Male; Methoxyhydroxyphenylglycol; Nerve Net; Parkinson Disease; Pars Compacta; Rats; Rats, Wistar; Sleep Stages | 2016 |
Functional effects of cardiac sympathetic denervation in neurogenic orthostatic hypotension.
Topics: Adrenergic beta-Agonists; Aged; Autonomic Nervous System Diseases; Blood Pressure; Dopamine; Female; Heart; Hemodynamics; Humans; Hypotension, Orthostatic; Isoproterenol; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Parkinson Disease; Radionuclide Imaging; Statistics, Nonparametric; Sympathectomy; Sympathomimetics; Tyramine | 2009 |
Generalized and neurotransmitter-selective noradrenergic denervation in Parkinson's disease with orthostatic hypotension.
Topics: Aged; Blood Pressure; Bradycardia; Cholinesterase Inhibitors; Edrophonium; Epinephrine; Female; Glucagon; Humans; Hypotension, Orthostatic; Isoproterenol; Male; Methoxyhydroxyphenylglycol; Microdialysis; Middle Aged; Muscle, Skeletal; Norepinephrine; Parkinson Disease; Pure Autonomic Failure; Tyramine; Yohimbine | 2008 |
N-acetylcysteine protects against apoptosis through modulation of group I metabotropic glutamate receptor activity.
Topics: Acetylcysteine; Animals; Apoptosis; Cell Line; Cell Survival; Disease Models, Animal; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Free Radical Scavengers; Methoxyhydroxyphenylglycol; Oxidation-Reduction; Parkinson Disease; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Metabotropic Glutamate; Staurosporine | 2012 |
Plasma levels of catechols and metanephrines in neurogenic orthostatic hypotension.
Topics: Adrenal Medulla; Aged; Autonomic Nervous System Diseases; Catechols; Epinephrine; Female; Heart Conduction System; Humans; Male; Metanephrine; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Normetanephrine; Parkinson Disease; Shy-Drager Syndrome; Supine Position; Sympathetic Nervous System | 2003 |
mGluRs: a target for pharmacotherapy in Parkinson disease.
Topics: Amino Acids, Dicarboxylic; Animals; Autoradiography; Basal Ganglia; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Glucose; Immunohistochemistry; Methoxyhydroxyphenylglycol; Oxidopamine; Parkinson Disease; Proto-Oncogene Proteins c-fos; Rats; Receptors, Metabotropic Glutamate | 2003 |
Intrapallidal metabotropic glutamate receptor activation in a rat model of Parkinson's disease: behavioral and histological analyses.
Topics: Adrenergic Agents; Analysis of Variance; Animals; Behavior, Animal; Dioxolanes; Disease Models, Animal; Drug Interactions; Excitatory Amino Acid Antagonists; Female; Globus Pallidus; Methoxyhydroxyphenylglycol; Motor Activity; Oxidopamine; Parkinson Disease; Proto-Oncogene Proteins c-fos; Purines; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase | 2008 |
Effects of L-DOPA on the excretion of alcoholic metabolites of catecholamines and trace amines in rat and human urine.
Topics: 3-Methoxy-4-hydroxyphenylethanol; Amines; Animals; Dopamine; Gas Chromatography-Mass Spectrometry; Humans; Levodopa; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Parkinson Disease; Phenylethyl Alcohol; Rats | 1981 |
Levodopa and deprenyl treatment effects on peripheral indices of oxidant stress in Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Aged, 80 and over; Cysteinyldopa; Humans; Levodopa; Malondialdehyde; Methoxyhydroxyphenylglycol; Middle Aged; Oxidative Stress; Parkinson Disease; Selegiline | 1996 |
Plasma catechols and monoamine oxidase metabolites in untreated Parkinson's and Alzheimer's diseases.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Aged, 80 and over; Alzheimer Disease; Blood Platelets; Catecholamines; Epinephrine; Female; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase; Norepinephrine; Parkinson Disease | 1996 |
Cardiac sympathetic denervation in Parkinson disease.
Topics: Adult; Aged; Blood Pressure; Brain; Cardiac Catheterization; Diagnosis, Differential; Dopamine; Female; Fluorine Radioisotopes; Heart; Heart Rate; Humans; Levodopa; Male; Methoxyhydroxyphenylglycol; Middle Aged; Multiple System Atrophy; Myocardium; Norepinephrine; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Tritium; Valsalva Maneuver | 2000 |
Determination of 3-methoxy-4-hydroxyphenylpyruvic acid, 3,4-dihydroxyphenylethylene glycol, and 3,4-dihydroxyphenylmandelic acid in urine by mass fragmentography, with use of deuterium-labeled internal standards.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Catechols; Child; Child, Preschool; Deuterium; Dopamine; Ethylene Glycols; Gas Chromatography-Mass Spectrometry; Humans; Infant; Infant, Newborn; Levodopa; Mandelic Acids; Methoxyhydroxyphenylglycol; Middle Aged; Neuroblastoma; Parkinson Disease; Phenylpyruvic Acids; Pheochromocytoma; Reference Standards; Reference Values; Shock, Cardiogenic | 1978 |
[Development of a liquid chromatography/multiple electrochemical detector (LCMC) and its application in neuroscience].
Topics: Animals; Brain Chemistry; Chromatography, High Pressure Liquid; Electrochemistry; Male; Methoxyhydroxyphenylglycol; Parkinson Disease; Rats; Rats, Inbred Strains; Tremor; Vanilmandelic Acid | 1991 |